Literature DB >> 16473673

Regulation of hMSH2 and hMLH1 expression in the human colon cancer cell line SW1116 by DNA methyltransferase 1.

Jing Yuan Fang1, Rong Lu, Judy A Mikovits, Zhong Hua Cheng, Hong Yin Zhu, Ying Xuan Chen.   

Abstract

Aberrant DNA methylation is now recognized as an important epigenetic alteration occurring early in human cancer. To directly study the role of DNA methyltransferase 1 (DNMT1) in the regulation of expression of tumor-related genes in human colon cancer cells, we stably transfected expression constructs containing sense or antisense DNMT1 into the human colon cancer cell line, SW1116. The expression level of mismatch repair genes (MMR), human mut-L homologue 1 (hMLH1) and human Mut S homologue 2 (hMSH2), was monitored by real-time RT-PCR. The methylation status of hMLH1 and hMSH2 promoters was determined by bisulfite modification and methylation-specific PCR (MSP). The protein levels of DNMT1, hMSH2 and hMLH1 were determined by Western analysis. The results show that DNMT1 protein expression was increased or decreased in transfected cell lines containing sense or antisense DNMT1 constructs, respectively. In cells expressing the sense DNMT1 construct, the expression of hMLH1 and hMSH2 was down-regulated through hypermethylation of their respective promoters. Furthermore, antisense DNMT1 expression induced promoter demethylation and up-regulated transcription of hMSH2 (P<0.05) and hMLH1 (P=0.064) in SW1116 cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16473673     DOI: 10.1016/j.canlet.2005.03.005

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

1.  The FENDRR/miR-214-3P/TET2 axis affects cell malignant activity via RASSF1A methylation in gastric cancer.

Authors:  Zhaocai He; Xin Wang; Changhao Huang; Yu Gao; Chen Yang; Pengwei Zeng; Zihua Chen
Journal:  Am J Transl Res       Date:  2018-10-15       Impact factor: 4.060

Review 2.  The Future of ctDNA-Defined Minimal Residual Disease: Personalizing Adjuvant Therapy in Colorectal Cancer.

Authors:  Alisha Bent; Shreya Raghavan; Arvind Dasari; Scott Kopetz
Journal:  Clin Colorectal Cancer       Date:  2022-03-26       Impact factor: 4.035

3.  MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer.

Authors:  E K O Ng; W P Tsang; S S M Ng; H C Jin; J Yu; J J Li; C Röcken; M P A Ebert; T T Kwok; J J Y Sung
Journal:  Br J Cancer       Date:  2009-07-28       Impact factor: 7.640

4.  Differential MSH2 promoter methylation in blood cells of Neurofibromatosis type 1 (NF1) patients.

Authors:  Sabrina Titze; Hartmut Peters; Sandra Währisch; Thomas Harder; Katrin Guse; Annegret Buske; Sigrid Tinschert; Anja Harder
Journal:  Eur J Hum Genet       Date:  2010-01       Impact factor: 4.246

5.  Combined inhibition of Dnmt and mTOR signaling inhibits formation and growth of colorectal cancer.

Authors:  Yan-Jie Zhang; Shu-Liang Zhao; Xiao-Qing Tian; Dan-Feng Sun; Hua Xiong; Qiang Dai; Xiao-Qiang Li; Jing-Yuan Fang
Journal:  Int J Colorectal Dis       Date:  2009-02-20       Impact factor: 2.571

6.  The expression and clinical significance of DNA methyltransferase proteins in human gastric cancer.

Authors:  Wen-Jin Ding; Jing-Yuan Fang; Xiao-Yu Chen; Yan-Shen Peng
Journal:  Dig Dis Sci       Date:  2008-02-06       Impact factor: 3.199

7.  Promoter methylation of MLH1, PMS2, MSH2 and p16 is a phenomenon of advanced-stage HCCs.

Authors:  Inga Hinrichsen; Matthias Kemp; Jan Peveling-Oberhag; Sandra Passmann; Guido Plotz; Stefan Zeuzem; Angela Brieger
Journal:  PLoS One       Date:  2014-01-06       Impact factor: 3.240

8.  Association of self-DNA mediated TLR9-related gene, DNA methyltransferase, and cytokeratin protein expression alterations in HT29-cells to DNA fragment length and methylation status.

Authors:  István Fűri; Ferenc Sipos; Sándor Spisák; Gergő Kiszner; Barnabás Wichmann; Andrea Schöller; Zsolt Tulassay; Györgyi Műzes; Béla Molnár
Journal:  ScientificWorldJournal       Date:  2013-12-29

9.  miR-19a/b and MeCP2 repress reciprocally to regulate multidrug resistance in gastric cancer cells.

Authors:  Fei Zhu; Qiong Wu; Zhen Ni; Chao Lei; Ting Li; Yongquan Shi
Journal:  Int J Mol Med       Date:  2018-03-22       Impact factor: 4.101

10.  MTHFR C677T polymorphisms are associated with aberrant methylation of the IGF-2 gene in transitional cell carcinoma of the bladder.

Authors:  Huan Cheng; Zhonglei Deng; Zengjun Wang; Wei Zhang; Jiantang Su
Journal:  J Biomed Res       Date:  2012-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.